Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival

被引:56
作者
Johnson, GA
Mannel, R
Khalifa, M
Walker, JL
Wren, M
Min, KW
Benbrook, DM
机构
[1] MEM UNIV NEWFOUNDLAND,DEPT PATHOL,ST JOHNS,NF A1C 5S7,CANADA
[2] DEACONESS HOSP,OKLAHOMA CITY,OK 73112
关键词
D O I
10.1006/gyno.1997.4660
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To evaluate the level of epidermal growth factor receptor (EGF-R) expression in vulvar malignancies and to determine if a correlation exists between EGF-R levels and metastasis or patient survival. Methods. All patients with a diagnosis of invasive squamous cell carcinoma of the vulva who were treated at our institution with a primary radical vulvectomy and inguinal lymph node dissection from 1983 to 1993 were eligible for the study. Sixty-one patients with available tissue blocks of benign vulvar epithelium, the primary malignant vulvar lesion, and groin node metastasis (when positive) were included in the study. Semiquantitative EGF-R expression was determined in a blinded fashion utilizing immunohistochemical staining of appropriate tissue samples. Survival was calculated utilizing Kaplan-Meier life table analysis based upon disease-free survival. Results. A significant increase (P < 0.001) in mean EGF-R levels was demonstrated in the primary tumor (67%) versus benign vulvar epithelium (31%). In the 14 patients with lymph node metastasis, the mean EGF-R level in the primary tumor was 65% versus 88% in the metastatic lesion (P < 0.001). The likelihood of lymph node metastasis was elevated in those patients with a benign tissue EGF-R level greater than or equal to 40% (P < 0.03) and in those patients with a primary tumor EGF-R level greater than or equal to 90% (P < 0.025). Life table analysis revealed a cumulative disease-free survival of 45% for all patients. Disease-free survival in those patients with EGF-R levels greater than or equal to 90% in the primary tumor was 25%, contrasting with a disease-free survival of 54% in those patients with EGF-R levels <90% (P < 0.05). Conclusions. There is a progressive increase in EGF-R expression from benign vulvar epithelium to primary malignant tissue to metastatic lesions within the same patient. Increased expression of EGF-R in the primary vulvar malignancy is significantly associated with lymph node metastasis and decreased patient survival. Increased expression of EGF-R in histologically benign vulvar epithelium has a significant association with lymph node metastasis and may predict decreased patient survival. (C) 1997 Academic Press.
引用
收藏
页码:425 / 429
页数:5
相关论文
共 49 条
[1]   EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN NORMAL OVARIAN EPITHELIUM AND OVARIAN-CANCER .1. CORRELATION OF RECEPTOR EXPRESSION WITH PROGNOSTIC FACTORS IN PATIENTS WITH OVARIAN-CANCER [J].
BERCHUCK, A ;
RODRIGUEZ, GC ;
KAMEL, A ;
DODGE, RK ;
SOPER, JT ;
CLARKEPEARSON, DL ;
BAST, RC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (02) :669-674
[2]  
BERCHUCK A, 1990, OBSTET GYNECOL, V76, P381
[3]   EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN NORMAL AND MALIGNANT ENDOMETRIUM [J].
BERCHUCK, A ;
SOISSON, AP ;
OLT, GJ ;
SOPER, JT ;
CLARKEPEARSON, DL ;
BAST, RC ;
MCCARTY, KS .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 161 (05) :1247-1252
[4]  
BIGSBY RM, 1992, OBSTET GYNECOL, V79, P95
[5]   TISSUE-SPECIFIC TRANSFORMATION BY ONCOGENIC MUTANTS OF EPIDERMAL GROWTH-FACTOR RECEPTOR [J].
CARTER, TH ;
KUNG, HJ .
CRITICAL REVIEWS IN ONCOGENESIS, 1994, 5 (04) :389-428
[6]   EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION AND THE PRESENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS [J].
CHAPMAN, WB ;
LORINCZ, AT ;
WILLETT, GD ;
WRIGHT, VC ;
KURMAN, RJ .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1992, 11 (03) :221-226
[7]  
CHEN JK, 1987, CANCER RES, V47, P4995
[8]   EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND SURVIVAL IN UPPER AERODIGESTIVE TRACT CANCER [J].
DASSONVILLE, O ;
FORMENTO, JL ;
FRANCOUAL, M ;
RAMAIOLI, A ;
SANTINI, J ;
SCHNEIDER, M ;
DEMARD, F ;
MILANO, G .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) :1873-1878
[9]  
DISAIA PJ, 1993, CLIN GYNECOLOGIC ONC, P37
[10]   EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFR) EXPRESSION IN NONSMALL CELL LUNG CARCINOMAS CORRELATES WITH METASTATIC INVOLVEMENT OF HILAR AND MEDIASTINAL LYMPH-NODES IN THE SQUAMOUS SUBTYPE [J].
FONTANINI, G ;
VIGNATI, S ;
BIGINI, D ;
MUSSI, A ;
LUCCHI, H ;
ANGELETTI, CA ;
PINGITORE, R ;
PEPE, S ;
BASOLO, F ;
BEVILACQUA, G .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (02) :178-183